Literature DB >> 9555636

A radical rupture in the paradigm of modern medicine: conflicts of interest, fiduciary obligations, and the scientific ideal.

G Khushf1.   

Abstract

Conflicts of interest serve as a cipher for a radical rupture in the Flexnerian paradigm of medicine, and they can only be addressed if we recognize that health care is now practiced by institutions, not just individual physicians. By showing how "appropriate utilization of services" or "that which is medically indicated" is a function of socioeconomic factors related to institutional responsibilities, I point toward an administrative and organizational ethic as a needed component for addressing conflicts of interest. The argument is developed by reviewing three important books. First, I consider Mark Rodwin's attempt to configure the economic structures of medicine so that classical fiduciary and scientific ideals can be fostered. Second, I consider E. Haavi Morreim's attempt to modify the classical ideals in order to account for new economic realities. Finally, by considering essays in a recent volume on conflicts of interest edited by Spece, Shimm, and Buchanan, I argue for a constructive dialectic between the approaches of Rodwin and Morreim. In order to properly address conflicts of interest, there must be a radical reassessment of medicine that accounts for the interrelation between scientific, ethical, and economic concerns. Until institutions come into view and professional ethics is developed to account for their role, legitimate interests and obligations of diverse parties cannot be harmonized.

Entities:  

Keywords:  Analytical Approach; Balancing Act: The New Medical Ethics of Medicine's New Economics (Morreim, E.H.); Conflicts of Interest in Clinical Practice and Research (Spece, R. et al., eds.); Health Care and Public Health; Medicine, Money and Morals: Physician's Conflicts of Interest (Rodwin, M.)

Mesh:

Year:  1998        PMID: 9555636     DOI: 10.1076/jmep.23.1.98.2591

Source DB:  PubMed          Journal:  J Med Philos        ISSN: 0360-5310


  5 in total

1.  The revised Canadian Guidelines for the Economic Evaluation of Pharmaceuticals.

Authors:  J L Glennie; G W Torrance; J F Baladi; C Berka; E Hubbard; D Menon; N Otten; M Rivière
Journal:  Pharmacoeconomics       Date:  1999-05       Impact factor: 4.981

2.  Core values: an ethics committee's foray into management theory.

Authors:  R D Pentz
Journal:  HEC Forum       Date:  2000-09

Review 3.  The aesthetics of clinical judgment: exploring the link between diagnostic elegance and effective resource utilization.

Authors:  G Khushf
Journal:  Med Health Care Philos       Date:  1999

4.  An agenda for future debate on concepts of health and disease.

Authors:  George Khushf
Journal:  Med Health Care Philos       Date:  2007-03

5.  The Institute of Medicine's reports on quality and safety: paradoxes and tensions.

Authors:  George Khushf; James Raymond; Charles Beaman
Journal:  HEC Forum       Date:  2008-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.